Why Altria (MO) is a Top Growth Stock for the Long-Term

Altria (MO) is positioned as a long-term growth stock, driven by its strategic pivot from traditional cigarettes to expanding its higher-revenue smokeless and oral product categories amid evolving industry dynamics. The company holds a Zacks Rank #2 (Buy) with a Growth Style Score of B and VGM Score of B, supported by a forecasted 4.9% year-over-year earnings growth for the current fiscal year. Recent positive indicators include an upward revision to its FY2025 earnings estimate to $5.37 per share and a consistent +1.3% average earnings surprise, suggesting MO warrants investor consideration.

Analysis

Altria (MO) is presented with a favorable outlook based on its strategic adaptation to shifting industry dynamics and supportive quantitative metrics. The company is actively moving beyond its legacy cigarette business to expand in the smokeless and oral product categories, where it is reportedly seeing steady revenue growth in response to rising health consciousness and regulatory pressures. This strategic pivot is underpinned by positive financial signals, including a forecasted 4.9% year-over-year earnings growth for the current fiscal year and a consistent history of beating estimates, evidenced by a +1.3% average earnings surprise. Furthermore, the consensus earnings estimate for fiscal 2025 has been revised upward to $5.37 per share. According to the provided proprietary ratings, Altria holds a #2 (Buy) rank and scores a 'B' for both its overall VGM and its specific Growth Style, indicating a positive outlook based on current earnings trends.

Key Decisions for Investors

• Given the #2 (Buy) rating, 4.9% forecasted earnings growth, and positive estimate revisions, investors may consider Altria a candidate for a growth-oriented portfolio.
• It is crucial to monitor future earnings reports for continued revenue growth in the oral and smokeless product categories to validate that the company's strategic pivot remains on track.
• Investors should weigh the positive outlook against the underlying industry risk of declining traditional tobacco consumption, as the bull case hinges on the successful transition to new product lines.